Progyny (formerly Auxogyn)

Auxogyn is revolutionizing the field of reproductive medicine by translating scientific discoveries in early embryo development into valuable clinical tools. The Company’s flagship product, the Eeva™ Test, is designed to deliver consistent, objective and quantitative information regarding embryo viability that reproductive endocrinologists and infertility patients can use to make important treatment decisions.
Menlo Park, US
70 (est)-4%
Progyny (formerly Auxogyn) was founded in 2008 and is headquartered in Menlo Park, US

Key People at Progyny (formerly Auxogyn)

Darrin Uecker

Darrin Uecker

Chief Operating Officer
Gina Bartasi

Gina Bartasi

Chief Executive Officer
Brian Dow

Brian Dow

Chief Financial Officer

Progyny (formerly Auxogyn) Locations

Menlo Park, US

Progyny (formerly Auxogyn) Metrics

Progyny (formerly Auxogyn) Summary

Founding Date


Total Funding

$78.3 M

Latest funding size

$34.3 M

Time since last funding

over 1 year


Progyny (formerly Auxogyn)'s latest funding round of $34.3 M was in March 2015. In total, Progyny (formerly Auxogyn) has raised $78.3 M.
33% of current employees of Progyny (formerly Auxogyn) are female and 67% are male.

Progyny (formerly Auxogyn) Company Life

You may also be interested in